Clinical Trial Update: Patient Compliance During PegIntron and Rebetol Combination Therapy in Chronic Hepatitis C (Study P04690)

View source ↗

Summary

A completed clinical trial (P04690) provides an update on patient compliance during pegylated interferon alfa-2b plus ribavirin therapy for chronic hepatitis C,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Rebetol (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Chronic, Hepatitis C | Status: COMPLETED | Results posted: 2011-11-18